How we treat primary immune thrombocytopenia in adults.
Liu XG, Hou Y, Hou M.
J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z.
Immune thrombocytopenia (ITP) in pregnancy.
Bussel JB, Knightly KA.
Br J Haematol. 2024 Apr;204(4):1176-1177. doi: 10.1111/bjh.19230. Epub 2024 Jan 23.
Treatment of drug-induced immune thrombocytopenias.
Marini I, Uzun G, Jamal K, Bakchoul T.
Haematologica. 2022 Jun 1;107(6):1264-1277. doi: 10.3324/haematol.2021.279484.
Thrombopoietin receptor agonists: ten years later.
Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB.
Haematologica. 2019 Jun;104(6):1112-1123. doi: 10.3324/haematol.2018.212845. Epub 2019 May 9.
Novel therapeutics and future directions for refractory immune thrombocytopenia.
Al-Samkari H, Neufeld EJ.
Br J Haematol. 2023 Oct;203(1):65-78. doi: 10.1111/bjh.19078.
Purpura Fulminans in Toxic Epidermal Necrolysis: Case Report and Review.
Jones E, Stair-Buchmann M, Kotliar S, Haith L.
J Burn Care Res. 2015 Nov-Dec;36(6):e274-82. doi: 10.1097/BCR.0000000000000195.
Avatrombopag for the Treatment of Immune Thrombocytopenia.
Labanca C, Vigna E, Martino EA, Bruzzese A, Mendicino F, Caridà G, Lucia E, Olivito V, Puccio N, Neri A, Morabito F, Gentile M.
Eur J Haematol. 2025 May;114(5):733-746. doi: 10.1111/ejh.14395. Epub 2025 Feb 4.
Nivolumab-induced toxic epidermal necrolysis with retiform purpura.
Basu P, Tong Y, Hinds BR, Schneider JA.
Br J Dermatol. 2020 Aug;183(2):e32. doi: 10.1111/bjd.19031. Epub 2020 Apr 13.
[Toxic thrombocytopenic purpura].
Górski J, Czestochowska E, Kicińska M.
Pol Tyg Lek. 1987 Mar 16;42(11):315-7.
Drug-induced immune thrombocytopenia.
van den Bemt PM, Meyboom RH, Egberts AC.
Drug Saf. 2004;27(15):1243-52. doi: 10.2165/00002018-200427150-00007.
